Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|July 22, 2014
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemiaAnjali S Advani, Shannon McDonough, Edward Copelan, et al.
Leukemia Research|November 28, 2013
High rate of uncaptured myelodysplastic syndrome cases and an improved method of case ascertainmentChristopher R Cogle, Michelle R Iannacone, Daohai Yu, et al.
Scientific Reports|May 27, 2016
Improved intra-array and interarray normalization of peptide microarray phosphorylation for phosphorylome and kinome profiling by rational selection of relevant spotsJetse Scholma, Gwenny M Fuhler, Jos Joore, et al.
Health and Quality of Life Outcomes|September 10, 2009
Valuation of transfusion-free living in MDS: results of health utility interviews with patientsAgota Szende, Caroline Schaefer, Thomas F Goss, et al.
Blood|May 10, 2011
A phase 2 study of lenalidomide monotherapy in patients with deletion 5q acute myeloid leukemia: Southwest Oncology Group Study S0605Mikkael A Sekeres, Holly Gundacker, Jeffrey Lancet, et al.
Leukemia Research|February 7, 2018
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)Anjali S Advani, Hongli Li, Laura C Michaelis, et al.
Cancer|June 10, 2011
Continued azacitidine therapy beyond time of first response improves quality of response in patients with higher-risk myelodysplastic syndromesLewis R Silverman, Pierre Fenaux, Ghulam J Mufti, et al.
Plos One|December 4, 2014
Lenalidomide induces lipid raft assembly to enhance erythropoietin receptor signaling in myelodysplastic syndrome progenitorsKathy L McGraw, Ashley A Basiorka, Joseph O Johnson, et al.
Clinical Lymphoma, Myeloma & Leukemia|September 5, 2017
The Treatment Landscape of Myelofibrosis Before and After Ruxolitinib ApprovalAndrew T Kuykendall, Chetasi Talati, Najla Al Ali, et al.
Leukemia Research|January 21, 2014
Cladribine, cytarabine, filgrastim, and mitoxantrone (CLAG-M) compared to standard induction in acute myeloid leukemia from myelodysplastic syndrome after azanucleoside failureMichael V Jaglal, Vu H Duong, Celeste M Bello, et al.
Pageof 20